LV UNO and Anti-rPD-L1 Doubled Survival by Day 37 versus Anti-rPD-L1 Alone

LV UNO and Anti-rPD-L1 Doubled Survival by Day 37 versus Anti-rPD-L1 Alone

Anti-rPD-L1 mAb in combination with either 25,000 ppm or 100,000 ppm UNO resulted in prolonged survival

Format

JPEG

Source

Beyond Airâ„¢

Downloads